期刊文献+

脓毒症患儿内生吗啡动态变化及临床意义

The Dynamic Change and Clinical Significance of Serum Endogenous Morphine in Children with Sepsis
原文传递
导出
摘要 目的:检测脓毒症患儿血清内生吗啡(EM)动态变化,探讨脓毒症患儿血清EM水平的临床意义。方法:选择2017年6月-2018年2月华中科技大学同济医学院附属同济医院收治的30例伴有严重脓毒症或脓毒症休克的患儿作为脓毒症组,30例全身炎症反应综合征(SIRS)患儿作为SIRS组,30例健康儿童作为对照组。脓毒症组、SIRS组及对照组分别于入组后第1、3、6、9天抽取外周静脉血,采用免疫荧光法检测血清降钙素原(PCT)水平,采用酶联免疫吸附试验(ELISA)测定血清EM水平,采用流式细胞术(FCM)检测细胞免疫功能。结果:SIRS组、脓毒症组患儿的第1、3、6天血清PCT水平显著高于对照组,且随时间延长PCT水平逐渐降低,至第9天降至正常水平(P<0.05),而脓毒症组与SIRS组间血清PCT水平无统计学差异(P>0.05)。脓毒症组第1、3、6天血清EM水平均高于SIRS组(P<0.05),第9天两组血清EM水平比较差异无统计学意义(P>0.05)。脓毒症组EM水平随时间延长而降低,至第9天降至SIRS组的水平(P<0.05)。与SIRS组相比,第1天脓毒症组的CD3^+T细胞数量增多(P<0.05),两组CD4^+、CD8^+T细胞数量、CD4^+/CD8^+比例比较无统计学差异(P>0.05)。结论:脓毒症患儿中血清EM水平较高,有可能作为诊断脓毒症特异性较高的生物标志物。 Objective: To detect the dynamic changes of plasma endogenous morphine(EM) in children with sepsis and to explore the clinical significance of serum EM level in children with sepsis. Methods: 30 children with severe sepsis or septic shock treated in our hospital from June 2017 to February 2018 were selected as sepsis group. 30 children with systemic inflammatory response syndrome(SIRS) as SIRS group and 30 healthy children as control group. Peripheral venous blood was collected from sepsis group, SIRS group and control group at 1 day, 3 days, 6 days, 9 days after admission respectively. Serum calcitonin(PCT) level was detected by immunofluorescence, serum EM was measured by enzyme linked immunosorbent assay(ELISA), and cell immunologic function was detected by flow cytometry(FCM). Results: The level of serum PCT in SIRS group and sepsis group was significantly higher than that of control group at 1 day, 3 days, 6 days, as time went on, the level of PCT decreased gradually, and decreased to normal level at 9 days(P<0.05).There was no significant difference in serum PCT level between sepsis group and SIRS group(P>0.05). The serum EM level in sepsis group was higher than that in SIRS group at 1 day, 3 days, 6 days(P<0.05). There was no significant difference in serum EM level between the two groups at 9 days(P>0.05). The level of EM in sepsis group decreased with time and decreased to SIRS level at 9 days(P<0.05).Compared with the SIRS group, the number of CD3^+T cells in the sepsis group increased at 1 day(P<0.05), and there was no significant difference in the number of CD4^+ and CD8^+T cells and the proportion of CD4+/CD8+in the two groups(P>0.05). Conclusion: Serum EM level in children with sepsis are relatively higher and may be used as biomarkers for the diagnosis of sepsis.
作者 徐晶 张宏伟 刘骏 程维华 褚骏雄 XU Jing;ZHANG Hong-wei;LIU Jun;CHENG Wei-hua;CHU Jun-xiong(Department of ICU,Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology,Wuhan,Hubei 430000,China;Department oflCU,Xiaochang County First People's Hospital of Hubei Province,Xiaogan,Hubei,432900,China)
出处 《现代生物医学进展》 CAS 2018年第23期4430-4433,共4页 Progress in Modern Biomedicine
基金 中国人体器官捐献专项研究课题(CODRP2017004)
关键词 脓毒症 内生吗啡 全身炎症反应综合征 生物标志物 免疫功能 Sepsis Endogenous morphine Systemic inflammatory response syndrome Biomarker Immune function
  • 相关文献

参考文献6

二级参考文献21

  • 1Dellinger RP,Levy MM,Rhodes A. Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock,2012[J].Intensive Care Medicine,2013.165-228.
  • 2Markwart R, Condotta SA, Requardt RP, et al. Immunosuppression after sepsis : systemic inflammation and sepsis induce a loss of naive T-cells but no enduring cell-autonomous defects in T-cell function [ J ] . PLoS One, 2014, 9 ( 12 ) : e115094.
  • 3Tschaikowsky K, Hedwig-Geissing M, Braun GG, et al. Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis [ J ] . J Crit Care, 2011, 26 ( 1 ) : 54-64.
  • 4Gaieski DF, Edwards JM, Kallan M J, et al. Benchmarking the incidence and mortality of severe sepsis in the United States [ J ] . Crit Care Med, 2013, 41 ( 5 ) : 1167-1174.
  • 5Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis [J] . Am J Respir Crit Care Med, 2001, 164 ( 3 ) : 396-402.
  • 6Pierrakos C, Vincent JL. Sepsis biomarkers : a review [ J ] . Critical Care, 2010, 14 ( 1 ) : 1-18.
  • 7Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ ATS/SIS international sepsis definitions conference [J]. Intensive Care Med, 2003, 29 ( 4 ) : 530-538.
  • 8Palmiere C, Bardy D, Mangin P, et al. Value of sTREM-1, proealcitonin and CRP as laboratory parameters for postmortem diagnosis of sepsis [ J ] . J Infect, 2013, 67 ( 6 ) : 545-555.
  • 9Wang H, Zhang P, Chen W, et al. Serum microRNA signatures identified by Solexa sequencing predict sepsis patients' mortality : a prospective observational study [J]. PLoS One, 2012, 7 ( 6 ) : e38885.
  • 10Celik IH, Demirel G, Uras N, et al. The role of serum interleukin-6 and C-reactive protein levels for differentiating aetiology of neonatal sepsis [ J ]. Arch Argent Pediatr, 2015, 113 ( 6 ) : 534-537.

共引文献706

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部